Beijing Strong Biotechnologies,Inc. (300406.SZ) Stock

About Beijing Strong Biotechnologies,Inc.

Beijing Strong Biotechnologies, Inc. operates as a supplier of in-vitro diagnostic (IVD) solutions, encompassing both products and associated services, for markets within the People's Republic of China and globally. The firm's comprehensive product line includes offerings for clinical biochemistry, such as diagnostic reagents and sophisticated automated analyzers. Additionally, it provides coagulation-related items, including necessary reagents and automated analysis instrumentation. Furthermore, its serology division delivers blood type testing cards and advanced automated systems for blood grouping. This enterprise was established in 2001 and has its corporate headquarters situated in Beijing, China.

Beijing Strong Biotechnologies,Inc. is led by CEO Hongjun Liang, employs 998 people, headquartered in Beijing, CN, publicly traded since 2014.

over the past 52 weeks the stock has ranged between $10.52 and $16.05, and currently trades 29.2% below its 52-week high.

Official website: www.bsbe.com.cn

Beijing Strong Biotechnologies,Inc. (300406.SZ) — frequently asked questions